Sailong Pharmaceutical Group Co (SZSE:002898) EPS (Basic) : ¥0.05 (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Sailong Pharmaceutical Group Co EPS (Basic)?

Sailong Pharmaceutical Group Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2024 was ¥0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.05.

Sailong Pharmaceutical Group Co's EPS (Diluted) for the three months ended in Mar. 2024 was ¥0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.05.

Sailong Pharmaceutical Group Co's EPS without NRI for the three months ended in Mar. 2024 was ¥0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was -0.00.

During the past 3 years, the average EPS without NRI Growth Rate was 70.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 11 years, Sailong Pharmaceutical Group Co's highest 3-Year average EPS without NRI Growth Rate was 70.50% per year. The lowest was -45.00% per year. And the median was 1.60% per year.

Sailong Pharmaceutical Group Co EPS (Basic) Historical Data

The historical data trend for Sailong Pharmaceutical Group Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sailong Pharmaceutical Group Co EPS (Basic) Chart

Sailong Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

0.16

-0.38

-0.13

-0.21

0.05

Sailong Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EPS (Basic)	Get a 7-Day Free Trial															0.02	-	0.01	0.03	0.01

Sailong Pharmaceutical Group Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Sailong Pharmaceutical Group Co's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(9.534	-	0)	/	175.898
	=	0.05

Sailong Pharmaceutical Group Co's Basic EPS for the quarter that ended in Mar. 2024 is calculated as

Basic EPS (Q: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(1.624	-	0)	/	176.532
	=	0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.05

Sailong Pharmaceutical Group Co (SZSE:002898) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Sailong Pharmaceutical Group Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Sailong Pharmaceutical Group Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Sailong Pharmaceutical Group Co (SZSE:002898) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sailong Pharmaceutical Group Co Ltd (SZSE:002898) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 47, Haibin South Road, 2nd Floor, Everbright International Trade Center, Guangdong Province, Zhuhai, CHN, 519015

Website

http://www.sailong.cn

Zhuhai Sailong Pharmaceutical Co Ltd is the pharmaceutical company. It is mainly engaged in the development, production, marketing and technical services of pharmaceuticals. The company's products are mainly concentrated in the fields of the nervous system, cardiovascular and digestive system. The product range includes monosialin tetrahexose ganglioside sodium injections, brain protein hydrolyzate for injections, clindamycin phosphate for injections, pantoprazole sodium for injections and milrinon injections, among others.

Executives

Tang Lin	Director
Long Zhi Xiang	Director
Deng Yong Jun	Supervisors
Zhou Bei	Supervisors
Li Jian Feng	Directors, executives

Sailong Pharmaceutical Group Co (SZSE:002898) Headlines

No Headlines